Sarcopenia in the era of precision health: Toward personalized interventions for healthy longevity

被引:7
作者
Chen, Liang-Kung [1 ,2 ,3 ]
机构
[1] Taipei Vet Gen Hosp, Ctr Geriatr & Gerontol, 201 Sect 2,Shi Pai Rd, Taipei, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Ctr Hlth Longev & Aging Sci, Taipei, Taiwan
[3] Taipei Municipal Gan Dau Hosp, Taipei Vet Gen Hosp, Taipei, Taiwan
关键词
Aging; Androgen receptor; Ghrelin receptor; Pharmaceutical Research; Sarcopenia; SKELETAL-MUSCLE MASS; ASIAN WORKING GROUP; BODY-COMPOSITION; OLDER PERSONS; DIAGNOSIS; CONSENSUS; FAT; PERCENTAGE; STRENGTH; QUALITY;
D O I
10.1097/JCMA.0000000000001164
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sarcopenia, characterized by the progressive loss of skeletal muscle mass and function, significantly impacts health outcomes in older adults. This review explores the evolving landscape of sarcopenia research, with a particular focus on its unique characteristics in Asian populations and emerging pharmaceutical interventions. Recent studies have revealed distinct patterns of muscle mass decline in Asian adults, particularly in women, challenging the universal application of global sarcopenia diagnostic criteria. The Asian Working Group for Sarcopenia has proposed region-specific diagnostic criteria, acknowledging these ethnic variations. Prevalence estimates of sarcopenia vary widely, ranging from 10% to 40% in community-dwelling older adults. For specific chronic conditions, the prevalence of sarcopenia is notably higher, reaching 35% for cardiovascular diseases and 24.5% for chronic kidney disease. Sarcopenia is strongly associated with various chronic conditions, increasing the risk of falls by 1.5 to 3 times and significantly increasing mortality risk by 29% to 51%. Current management strategies primarily involve resistance exercise and nutritional interventions, with a recommended daily protein intake of at least 1.2 g/kg to maintain muscle health. Pharmaceutical development has gained significant momentum, with over 20 compounds in various stages of clinical trials. These include myostatin inhibitors, selective androgen receptor modulators, ghrelin receptor agonists, mesenchymal stem cell therapy, and follistatin gene therapy. However, the unique dietary patterns, cultural contexts, and potentially distinct drug responses in Asian populations necessitate tailored interventions and Asia-specific clinical trials. Future directions include refining Asian-specific diagnostic criteria, conducting large-scale epidemiological studies across multiple Asian countries, developing culturally appropriate interventions, integrating sarcopenia management into chronic disease care, and advancing pharmaceutical research with a focus on Asian populations. In conclusion, sarcopenia emerges as a critical nexus in the aging process, intricately linked with multiple organ systems and chronic conditions, underscoring the imperative for its recognition as a cornerstone in person-centered care and the holistic management of age-related health challenges.
引用
收藏
页码:980 / 987
页数:8
相关论文
共 78 条
[1]   Effect of perindopril or leucine on physical performance in older people with sarcopenia: the LACE randomized controlled trial [J].
Achison, Marcus ;
Adamson, Simon ;
Akpan, Asangaedem ;
Aspray, Terry ;
Avenell, Alison ;
Band, Margaret M. ;
Bashir, Tufail ;
Burton, Louise A. ;
Cvoro, Vera ;
Donnan, Peter T. ;
Duncan, Gordon W. ;
George, Jacob ;
Gordon, Adam L. ;
Gregson, Celia L. ;
Hapca, Adrian ;
Henderson, Emily ;
Hume, Cheryl ;
Jackson, Thomas A. ;
Kemp, Paul ;
Kerr, Simon ;
Kilgour, Alixe ;
Lyell, Veronica ;
Masud, Tahir ;
McKenzie, Andrew ;
McKenzie, Emma ;
Patel, Harnish ;
Pilvinyte, Kristina ;
Roberts, Helen C. ;
Rossios, Christos ;
Sayer, Avan A. ;
Smith, Karen T. ;
Soiza, Roy L. ;
Steves, Claire J. ;
Struthers, Allan D. ;
Sumukadas, Deepa ;
Tiwari, Divya ;
Whitney, Julie ;
Witham, Miles D. .
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2022, 13 (02) :858-871
[2]   Welcome to the ICD-10 code for sarcopenia [J].
Anker, Stefan D. ;
Morley, John E. ;
von Haehling, Stephan .
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2016, 7 (05) :512-514
[3]  
Asejeje FO., 2024, Arch. Gerontol. Geriatr. Plus, V1, DOI [10.1016/J.AGGP.2023.100003, DOI 10.1016/J.AGGP.2023.100003]
[4]  
Aspray Terry J, 2019, Subcell Biochem, V91, P453, DOI 10.1007/978-981-13-3681-2_16
[5]   Age-associated decline of muscle mass, grip strength and gait speed: A 4-year longitudinal study of 3018 community-dwelling older Chinese [J].
Auyeung, Tung Wai ;
Lee, Shun Wah Jenny ;
Leung, Jason ;
Kwok, Timothy ;
Woo, Jean .
GERIATRICS & GERONTOLOGY INTERNATIONAL, 2014, 14 :76-84
[6]   Effects of branched-chain amino acid-rich supplementation on EWGSOP2 criteria for sarcopenia in older adults: a systematic review and meta-analysis [J].
Bai, Geng-Hao ;
Tsai, Meng-Chen ;
Tsai, Han-Wei ;
Chang, Chun-Chao ;
Hou, Wen-Hsuan .
EUROPEAN JOURNAL OF NUTRITION, 2022, 61 (02) :637-651
[7]   Sarcopenia: A Time for Action. An SCWD Position Paper [J].
Bauer, Juergen ;
Morley, John E. ;
Schols, Annemie M. W. J. ;
Ferrucci, Luigi ;
Cruz-Jentoft, Alfonso J. ;
Dent, Elsa ;
Baracos, Vickie E. ;
Crawford, Jeffrey A. ;
Doehner, Wolfram ;
Heymsfield, Steven B. ;
Jatoi, Aminah ;
Kalantar-Zadeh, Kamyar ;
Lainscak, Mitja ;
Landi, Francesco ;
Laviano, Alessandro ;
Mancuso, Michelangelo ;
Muscaritoli, Maurizio ;
Prado, Carla M. ;
Strasser, Florian ;
von Haehling, Stephan ;
Coats, Andrew J. S. ;
Anker, Stefan D. .
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2019, 10 (05) :956-961
[8]   Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis [J].
Beaudart, Charlotte ;
Zaaria, Myriam ;
Pasleau, Francoise ;
Reginster, Jean-Yves ;
Bruyere, Olivier .
PLOS ONE, 2017, 12 (01)
[9]   Sarcopenia in COPD: a systematic review and meta-analysis [J].
Benz, Elizabeth ;
Trajanoska, Katerina ;
Lahousse, Lies ;
Schoufour, Josje D. ;
Terzikhan, Natalie ;
De Roos, Emmely ;
de Jonge, Gerdien B. ;
Williams, Ross ;
Franco, Oscar H. ;
Brusselle, Guy ;
Rivadeneira, Fernando .
EUROPEAN RESPIRATORY REVIEW, 2019, 28 (154)
[10]   Sarcopenia Definition: The Position Statements of the Sarcopenia Definition and Outcomes Consortium [J].
Bhasin, Shalender ;
Travison, Thomas G. ;
Manini, Todd M. ;
Patel, Sheena ;
Pencina, Karol M. ;
Fielding, Roger A. ;
Magaziner, Jay M. ;
Newman, Anne B. ;
Kiel, Douglas P. ;
Cooper, Cyrus ;
Guralnik, Jack M. ;
Cauley, Jane A. ;
Arai, Hidenori ;
Clark, Brian C. ;
Landi, Francesco ;
Schaap, Laura A. ;
Pereira, Suzette L. ;
Rooks, Daniel ;
Woo, Jean ;
Woodhouse, Linda J. ;
Binder, Ellen ;
Brown, Todd ;
Shardell, Michelle ;
Xue, Quian-Li ;
D'Agostino, Ralph B., Sr. ;
Orwig, Denise ;
Gorsicki, Greg ;
Correa-De-Araujo, Rosaly ;
Cawthon, Peggy M. .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2020, 68 (07) :1410-1418